IBC Patients Wanted For NIH Clinical Trials

Hi Buddies,



We know all too well how rare, aggressive and deadly Inflammatory Breast Cancer is. While we don't understand its exact cause and there is no cure, medical research is trying to provide some answers. And that's where you can help.

The National Cancer Institute at the National Institutes of Health is conducting clinical trials on Inflammatory Breast Cancer.

Researchers are studying the effects of high doses of chemotherapy, beyond the normal tolerance, and peripheral stem cell transplantation.

High doses of chemo kill the cancer but the chemo also destroys bone marrow. Through a procedure know as "apheresis" blood stem cells are harvested. Once the chemo is out of a patient's system, out of the blood, bone marrow cells are reinfused to make their way back to bone marrow and regenerate their bone marrow function.

The ongoing NCI study is a small one, but researchers are seeing positive results. High dose chemo along with a bone marrow transplant makes an IBC diagnosis equivalent to a standard Stage 3 cancer. That alone improves a patient's outcome significantly.

NIH needs IBC patients who are newly diagnosed and have not received prior treatment for IBC.

If you are interested and would like more information on your eligibility for you or your Buddy, contact the Clinical Trials Referral Office at 1-888-NCI-1937 (1-888-624-1937) Monday through Friday, 9:00 a.m. to 5:00 p.m. Eastern Standard Time or at ncicssc@mail.nih.gov. You can click on the link below. There is no charge for medical care received at NIH.

Take care,
Andrea Roane



IBC LINK
National Cancer Institute IBC Clinical Trials